Of these, IKBKE (inhibitor of nuclear factor kappa-B kinase subunit epsilon) and YBX1 (Y box binding protein 1) have been previously implicated in glioblastoma pathogenesis and metabolic targeting of virotherapy11,12. This evidence concerns the gene YBX1 and glioblastoma.